Skip to content
Search

Latest Stories

Submit Guest Post

Pfizer jab can be stored in fridge up to one month: EU drugs regulator

COMIRNATY, the Pfizer Covid vaccine can now be stored at fridge temperature for up to one month, the European Union's drugs regulator said.

The move has come to ease the vaccine’s roll-out across the world.


Although the need for transport and storage at very low temperatures has been one of the major disadvantages of the Pfizer jab with a limit of just five days.

While the previous storage requirements for Pfizer vaccines have made them harder to use in some parts of the world.

The approved storage conditions of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer will facilitate the handling of the vaccine in vaccination centres across the European Union (EU).

“This change extends the approved storage period of the unopened thawed vial at 2-8°C (i.e. in a normal fridge after taking out of deep-freeze conditions) from five days to one month (31 days),"

"Increased flexibility in the storage and handling of the vaccine is expected to have a significant impact on planning and logistics of vaccine roll-out in EU Member States,” said EMA in an official statement.

The changes will be included in the publicly available information on Comirnaty and will be implemented by the marketing authorisation holder in updated product labelling.

Users are reminded to always refer to the label and package leaflet of the supplied product for the correct storage information.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less